Malvern Panalytical collaborates with Domainex, a leading Contract Research Organization (CRO), to advance drug discovery with cutting-edge biophysics technology. Domainex uses Malvern Panalytical’s WAVEsystem and PEAQ-ITC instruments to measure drug-target binding kinetics, binding affinity, and thermodynamics in real-time.
Powered by Grating-Coupled Interferometry (GCI) technology, the WAVEsystem offers exceptional sensitivity for fragment screening and faster dissociation rates, providing efficient, high-quality results. The PEAQ-ITC Isothermal Titration Calorimeter provides gold-standard data using binding heat measurements to deliver key insights into binding affinity, thermodynamics, and stoichiometry.
Malvern Panalytical partners in discovery with Domainex, our advanced analytical solutions enhancing the CRO’s ability to provide fast, top-quality data, driving innovation in the life sciences and accelerating drug discovery – all helping to make the world cleaner, healthier and more productive.